InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Stelzer Laurie, Chief Financial Officer. Insider active across 2 companies, notably Arena Pharmaceuticals INC. Aggregated, 6 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €160k. History available since 3 January 2022. The latest transaction was disclosed on 9 August 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Stelzer Laurie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
22,297 shares@ US$37.0082.4% of flowCommon StockSEC:0001628280-23-028889:0
4,647 shares@ US$37.0617.6% of flowCommon StockSEC:0001628280-23-020720:0
26,864 shares0Common StockSEC:0001214659-23-001044:0
57,798 shares0Common StockSEC:0001214659-22-007823:0
9,086 sharesCommon StockSEC:0001628280-22-005891:0
21,462 shares0Common StockSEC:0001628280-22-000340:0
6 of 6 declarations
About Stelzer Laurie
Laurie Stelzer is the Executive Vice President and Chief Financial Officer at ARENA PHARMACEUTICALS INC and Mirati Therapeutics, Inc. She oversees the financial operations of both companies, including financial planning, risk management, and financial reporting. Laurie plays a crucial role in the overall financial strategy, contributing to the growth and sustainability of the companies. Her expertise in finance is a significant asset to the leadership teams.
